Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biotech company with a strong focus on clinical development. We discover and develop targeted small molecule drugs with an epigenetic mode of action for the treatment of cancer in indications with a high unmet medical need and major economic potential. In doing so, we wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life and create value for our shareholders, partners and employees.
Type
Public
HQ
Planegg, DE
Founded
1997
Employees
44 (est)
4SC was founded in 1997 and is headquartered in Planegg, DE

4SC Locations

Planegg, DE

4SC Metrics

4SC Summary

Market capitalization

€47.4 B

Closing share price

€2.42
4SC's latest market capitalization is €47.4 B.

4SC Market Value History

4SC Company Life

You may also be interested in